Companies
Gadea Pharma
supplies sterile corticosteroid APIs such as budesonide (oral and respiratory) for inhalation and other sterile applications, under the Minakem group.
- Country
- Spain
Commercial
Sterile corticoid API
Coverage
| CN | EU | US | |
|---|---|---|---|
| therapeutics-platforms | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Founded | $174 million acquisition by AMRI in 2015 | genengnews.com · pharmaceutical-technology.com · pharmtech.com · prnewswire.co.uk · sec.gov |
| Capacity | over 10 MT annually for budesonide API | minakem.com |
| Regulatory approval | 22 active US DMFs, 17 EU COSs, 13 Japanese DMFs, 2 South Korean DMFs | genengnews.com · pharmaceutical-technology.com · prnewswire.co.uk · sec.gov |
| Production site | Valladolid, Spain | cphi-online.com · pharmtech.com · prnewswire.co.uk · sec.gov |
| Revenue | approximately $83 million in 2014 | genengnews.com · pharmaceutical-technology.com · pharmtech.com · prnewswire.co.uk · sec.gov |
Independent sources: cphi-online.com · genengnews.com · minakem.com · pharmaceutical-technology.com · pharmtech.com · prnewswire.co.uk · sec.gov
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biosynthetic steroids (fermentation & biocatalytic API) | therapeutics-platforms | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.